4.8 Article

iRhom2 Promotes Hepatic Steatosis by Activating MAP3K7-Dependent Pathway

Related references

Note: Only part of the references are listed.
Editorial Material Gastroenterology & Hepatology

Of Mice and Men and Nonalcoholic Steatohepatitis

David A. Brenner

HEPATOLOGY (2018)

Editorial Material Gastroenterology & Hepatology

Trimming the Fat: Acetyl-CoA Carboxylase Inhibition for the Management of NAFLD

Norihiro Imai et al.

HEPATOLOGY (2018)

Article Nanoscience & Nanotechnology

Activated iRhom2 drives prolonged PM2.5 exposure-triggered renal injury in Nrf2-defective mice

Min-Xuan Xu et al.

NANOTOXICOLOGY (2018)

Review Endocrinology & Metabolism

JNK at the crossroad of obesity, insulin resistance, and cell stress response

Giovanni Solinas et al.

MOLECULAR METABOLISM (2017)

Review Cell Biology

The role of macrophages in obesity-driven chronic liver disease

Lindsey Devisscher et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2016)

Review Cardiac & Cardiovascular Systems

Obesity and cardiovascular outcomes: a review

Kuldeepa Ghoorah et al.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2016)

Review Endocrinology & Metabolism

Obesity, inflammation, and the gut microbiota

Amanda J. Cox et al.

LANCET DIABETES & ENDOCRINOLOGY (2015)

Article Hematology

iRhom2 is required for the secretion of mouse TNFα

Owen M. Siggs et al.

BLOOD (2012)